[Behavior of CPK, SGOT, SGPT and aldolase following oral administration of a new specific adrenergic beta-2 bronchodilator (Clenbuterol)].
D000284:Administration, Oral; D000402:Airway Obstruction / Q000188:drug therapy; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D003402:Creatine Kinase / Q000097:blood*; D005260:Female; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010627:Phenethylamines / Q000008:administration & dosage*; D000637:Transaminases / Q000097:blood*
D010627:Phenethylamines; D000637:Transaminases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase; D005634:Fructose-Bisphosphate Aldolase
Das Verhalten der CPK, SGOT, SGPT und Aldolase nach oraler Applikation eines neuen spezifisch-adrenergen beta2-Bronchodilators (Clenbuterol)